Cargando…

An equity‐based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma

OBJECTIVES: The majority of patients with head and neck squamous cell carcinoma (HNSCC) do not commence postoperative radiation treatment (PORT) within the recommended 6 weeks. We explore how delayed PORT affects survival outcomes, what factors are associated with delayed PORT initiation, and what i...

Descripción completa

Detalles Bibliográficos
Autores principales: Noyes, Elizabeth A., Burks, Ciersten A., Larson, Andrew R., Deschler, Daniel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665479/
https://www.ncbi.nlm.nih.gov/pubmed/34938875
http://dx.doi.org/10.1002/lio2.692
_version_ 1784614017855127552
author Noyes, Elizabeth A.
Burks, Ciersten A.
Larson, Andrew R.
Deschler, Daniel G.
author_facet Noyes, Elizabeth A.
Burks, Ciersten A.
Larson, Andrew R.
Deschler, Daniel G.
author_sort Noyes, Elizabeth A.
collection PubMed
description OBJECTIVES: The majority of patients with head and neck squamous cell carcinoma (HNSCC) do not commence postoperative radiation treatment (PORT) within the recommended 6 weeks. We explore how delayed PORT affects survival outcomes, what factors are associated with delayed PORT initiation, and what interventions exist to reduce delays in PORT initiation. METHODS: We conducted a PubMed search to identify articles discussing timely PORT for HNSCC. We performed a narrative review to assess survival outcomes of delayed PORT as well as social determinants of health (SDOH) and clinical factors associated with delayed PORT, using the PROGRESS‐Plus health equity framework to guide our analysis. We reviewed interventions designed to reduce delays in PORT. RESULTS: Delayed PORT is associated with reduced overall survival. Delays in PORT disproportionately burden patients of racial/ethnic minority backgrounds, Medicaid or no insurance, low socioeconomic status, limited access to care, more comorbidities, presentation at advanced stages, and those who experience postoperative complications. Delays in PORT initiation tend to occur during transitions in head and neck cancer care. Delays in PORT may be reduced by interventions that identify patients who are most likely to experience delayed PORT, support patients according to their specific needs and barriers to care, and streamline care and referral processes. CONCLUSIONS: Both SDOH and clinical factors are associated with delays in timely PORT. Structural change is needed to reduce health disparities and promote equitable access to care for all. When planning care, providers must consider not only biological factors but also SDOH to maximize care outcomes.
format Online
Article
Text
id pubmed-8665479
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-86654792021-12-21 An equity‐based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma Noyes, Elizabeth A. Burks, Ciersten A. Larson, Andrew R. Deschler, Daniel G. Laryngoscope Investig Otolaryngol Head and Neck, and Tumor Biology OBJECTIVES: The majority of patients with head and neck squamous cell carcinoma (HNSCC) do not commence postoperative radiation treatment (PORT) within the recommended 6 weeks. We explore how delayed PORT affects survival outcomes, what factors are associated with delayed PORT initiation, and what interventions exist to reduce delays in PORT initiation. METHODS: We conducted a PubMed search to identify articles discussing timely PORT for HNSCC. We performed a narrative review to assess survival outcomes of delayed PORT as well as social determinants of health (SDOH) and clinical factors associated with delayed PORT, using the PROGRESS‐Plus health equity framework to guide our analysis. We reviewed interventions designed to reduce delays in PORT. RESULTS: Delayed PORT is associated with reduced overall survival. Delays in PORT disproportionately burden patients of racial/ethnic minority backgrounds, Medicaid or no insurance, low socioeconomic status, limited access to care, more comorbidities, presentation at advanced stages, and those who experience postoperative complications. Delays in PORT initiation tend to occur during transitions in head and neck cancer care. Delays in PORT may be reduced by interventions that identify patients who are most likely to experience delayed PORT, support patients according to their specific needs and barriers to care, and streamline care and referral processes. CONCLUSIONS: Both SDOH and clinical factors are associated with delays in timely PORT. Structural change is needed to reduce health disparities and promote equitable access to care for all. When planning care, providers must consider not only biological factors but also SDOH to maximize care outcomes. John Wiley & Sons, Inc. 2021-11-09 /pmc/articles/PMC8665479/ /pubmed/34938875 http://dx.doi.org/10.1002/lio2.692 Text en © 2021 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Head and Neck, and Tumor Biology
Noyes, Elizabeth A.
Burks, Ciersten A.
Larson, Andrew R.
Deschler, Daniel G.
An equity‐based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma
title An equity‐based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma
title_full An equity‐based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma
title_fullStr An equity‐based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma
title_full_unstemmed An equity‐based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma
title_short An equity‐based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma
title_sort equity‐based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma
topic Head and Neck, and Tumor Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665479/
https://www.ncbi.nlm.nih.gov/pubmed/34938875
http://dx.doi.org/10.1002/lio2.692
work_keys_str_mv AT noyeselizabetha anequitybasednarrativereviewofbarrierstotimelypostoperativeradiationtherapyforpatientswithheadandnecksquamouscellcarcinoma
AT burkscierstena anequitybasednarrativereviewofbarrierstotimelypostoperativeradiationtherapyforpatientswithheadandnecksquamouscellcarcinoma
AT larsonandrewr anequitybasednarrativereviewofbarrierstotimelypostoperativeradiationtherapyforpatientswithheadandnecksquamouscellcarcinoma
AT deschlerdanielg anequitybasednarrativereviewofbarrierstotimelypostoperativeradiationtherapyforpatientswithheadandnecksquamouscellcarcinoma
AT noyeselizabetha equitybasednarrativereviewofbarrierstotimelypostoperativeradiationtherapyforpatientswithheadandnecksquamouscellcarcinoma
AT burkscierstena equitybasednarrativereviewofbarrierstotimelypostoperativeradiationtherapyforpatientswithheadandnecksquamouscellcarcinoma
AT larsonandrewr equitybasednarrativereviewofbarrierstotimelypostoperativeradiationtherapyforpatientswithheadandnecksquamouscellcarcinoma
AT deschlerdanielg equitybasednarrativereviewofbarrierstotimelypostoperativeradiationtherapyforpatientswithheadandnecksquamouscellcarcinoma